Table 3.
Men (n = 20) | Women (n = 18) | P Value | |
---|---|---|---|
AHI, events/h | 25.0 (15.1, 44.5) | 21.5 (15.8, 122.3) | 0.75 |
Age, y | 43.5 ± 10.5 | 44.7 ± 10.2 | 0.73 |
BMI, kg/m2 | 33.3 (31.0, 37.6) | 41.7 (37.4, 47.3) | 0.003 |
Waist-to-hip ratio | 0.99 ± 0.07 | 0.88 ± 0.07 | < 0.001 |
%FMD | 5.7 ± 3.9 | 5.8 ± 3.7 | 0.91 |
%NID | 17.4 ± 5.4 | 19.8 ± 8.0 | 0.27 |
%Ach | 50.0 (33.3, 81.9) | 71.3 (38.8, 89.8) | 0.22 |
%SNp | 39.3 (21.1, 77.3) | 69.7 (43.7, 90.2) | 0.035 |
AIx (%) | 14.4 ± 8.2 | 27.1 ± 7.5 | < 0.001 |
Obstructive sleep apnea (OSA) was defined as an apnea-hypopnea index (AHI) ≥ 10 events/h.
For normally distributed data, mean ± SD are shown; for nonparametric distributed data, medians (25th, 75th percentiles) are represented. The augmentation index (AIx) is corrected to 75 bpm.
%FMD refers to the percentage change in brachial artery diameter after flow-mediated dilation; %NID, percentage change in brachial artery diameter after nitroglycerin-induced dilation; %Ach, percentage change in laser Doppler flowmetry of the skin microcirculation after iontophoresis of acetylcholine; %SNp, percentage change in laser Doppler flowmetry of the skin microcirculation after iontophoresis of sodium nitroprusside.